About this trial
The main goal is to understand what it is truly like to live with OAB from the patient's perspective, including how it affects: daily activities, emotional wellbeing and mental health, social life and relationships, work and overall quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
If they are over 18 years old.
They have been told by a doctor or other healthcare professional that they have symptoms that match OAB, or have been given a diagnosis of OAB.
They live in France, Germany, Italy, the Netherlands, Poland, Spain, Sweden, or the UK.
They have received the Patient Information Sheet from their health care provider, during an appointment, via email, or postal mail.
Disqualifiers
They have not received information on this study from their own health care provider
They have a confirmed neurological condition known to affect bladder function (for example: multiple sclerosis, Parkinson's disease, spinal cord injury).
They have undergone major surgery directly involving the bladder, prostate, urethra, or pelvic structures that affect urinary function.
They presently have a urinary tract infection (UTI).
Trial population
CHU Grenoble Alpes, France; Tenon Academic Hospital Paris, France; Universitätsklinikum Münster, Germany; Fondazione Policlinico Universitario Campus Bio-Medico of Rome Italy; Policlinico Tor Vergata University Hospital, Rome Italy; Urology Clinic at the Orlowski Hospital in Warsaw, Poland; Hospital Universitario Vitgen De Valme, Seville Spain; Complejo Hospitalario Universitario Insular Materno Infantil (CHUIMI), Gran Canaria Spain; Karolinska Institutet Solna, Stockholm Area, Sweden; Rijnstate Hospital Arnhem, the Netherlands, Maastricht UMC, the Netherlands; Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Trial design
Case-only
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Sexual matters
Participants achieved a response if they scored a bother status of 0 or 1 on a scale ranging from 0 (not at all) to 10 (a lot)
OAB symptom severity and frequency
Participants achieved a response if they scored a bother status of 0 or 1 on a scale ranging from 0 (not at all) to 10 (a great deal)
Quality of Life relating to bladder symptoms
1 is equivalent to 'none of the time' and 6 is equivalent to 'all of the time'
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
European Association of Urology Research Foundation
Lead sponsor
Medtronic
Collaborator
Astellas Pharma Europe B.V.
Collaborator
This trial is not recruiting at the moment. You can still explore other options: